arrow
M

Mathurin Fuméry

Institut national de la santé et de la recherche médicale
H指数:51
被引数:9,116

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID

炎症性肠病患者肠道急迫感、疾病活动度与残疾的相关性:一项来自GETAID的横断面研究

2026-08-010
PRE
Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study

甲氨蝶呤治疗炎症性肠病:MICI-METHO多中心回顾性队列研究

2026-07-220
PRE
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID

在溃疡性结肠炎中,继维多利珠单抗后的二线高级治疗的疗效与安全性:一项来自GETAID的多中心队列研究

2026-03-250
OAAI
Long-term disease course of Crohn’s disease in a prospective European population-based inception cohort – an Epi-IBD cohort study

克罗恩病长期疾病进程:一项前瞻性欧洲人群为基础的发病队列研究——Epi-IBD队列研究

2025-11-030
OAAI
Real-world comparison of effectiveness between ustekinumab and a second-line anti-TNF agent in patients with symptomatic stricturing Crohn’s disease failing to respond to a first-line anti-TNF agent: the USTEKNOSIS study

真实世界中,ustekinumab与二线抗TNF制剂在症状性狭窄型克罗恩病患者中的疗效比较:患者为对一线抗TNF制剂无应答者——USTEKNOSIS研究

2025-10-310
OA
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials

国际共识:肠道超声在炎症性肠病试验中的应用

2025-09-011
PRE
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID

皮下注射维多利珠单抗剂量强化在炎症性肠病患者中的应用:GETAID组织的OPTI-VEDO多中心研究

2025-09-010
PRE
The CROCO (CROhn’s Disease COhort Study) – study design and protocol

克罗恩病队列研究(CROCO,CROhn’s Disease COhort Study)——研究设计与方案

2025-08-290
OA
International Magnetic Resonance Imaging Consensus for use in Luminal Crohn’s Disease Trials and Clinical Practice

国际磁共振成像共识(用于管腔克罗恩病试验和临床实践)

2025-08-270
PRE
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study

比较标准与强化肺炎球菌疫苗接种方案在应用生物制剂治疗的炎症性肠病患者中的效果:一项前瞻性、多中心、随机、开放标签研究

2025-08-250
PRE
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis

托法替布与乌帕替尼治疗急性重度溃疡性结肠炎的疗效比较

2025-07-260
OAAI
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study

乌帕替尼诱导治疗223例克罗恩病患者的有效性与安全性:一项GETAID多中心队列研究

2025-03-042
OAAI